Prediction of fetal/embryonic metabolism is an important consideration in determining the risk associated with exposure of the fetus/embryo to potentially toxic compounds. The objective of this proposal is to utilize chemical substrate probes for analysis of the FUNCTIONAL P-450 isozyme composition and the accompanying capacity of fetal hepatic and extrahepatic tissues to catalyze regioselective metabolism of environmental toxins and prototype chemical carcinogens. Two types of probe, both of which exhibit restricted isozyme specificity, will be used in these studies; a) enantiomeric warfarin which produces a range of hydroxylated products from the parent molecule, and b) a series of phenoxazone ethers which are oxidized to a common metabolite. As test substrates, benzo(Alpha)pyrene (BP) and 2-acetylaminofluorene (AAF) will be employed. The proposal is based on the hypothesis that patterns of biotransformation of the two classes of chemical probes (warfarin and the phenoxazone ethers) will be highly predictive for the specific biotransformation of test substrates (BP and AAF). The hypothesis will be tested by 1) determining the goodness of fit for correlations of analyzed metabolic pathways under a variety of conditions and after perturbation by a series of regulatory agents, 2) making predictions based on the goodness of fit, and finally, 3) testing the predictability by analyzing tissues of unknown isozymic composition with the chemical probes and determining the degree to which these analyses predict BP and AAF metabolite profiles within the same tissues. The long-range goal of these investigations is to enable the ascertainment of P-450-dependent biotransforming and bioactivating capacities of fetal/embryonic tissues and others for which isolation and purification of the isozymic forms is impractical.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
1R01ES004342-01
Application #
3252447
Study Section
Toxicology Study Section (TOX)
Project Start
1986-09-15
Project End
1989-08-31
Budget Start
1986-09-15
Budget End
1987-08-31
Support Year
1
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Seegmiller, R E; Harris, C; Luchtel, D L et al. (1991) Morphological differences elicited by two weak acids, retinoic and valproic, in rat embryos grown in vitro. Teratology 43:133-50
Juchau, M R; Harris, C; Stark, K L et al. (1991) Cytochrome P450-dependent bioactivation of prodysmorphogens in cultured conceptuses. Reprod Toxicol 5:259-63
Lee, Q P; Yang, H Y; Namkung, M J et al. (1991) cAMP-dependent regulation of P450-catalyzed dealkylation in rat conceptal tissues. Reprod Toxicol 5:473-80
Stark, K L; Lee, Q P; Namkung, M J et al. (1990) Dysmorphogenesis elicited by microinjected acetaminophen analogs and metabolites in rat embryos cultured in vitro. J Pharmacol Exp Ther 255:74-82
Yang, H Y; Namkung, M J; Juchau, M R (1989) Immunodetection, immunoinhibition, immunoquantitation and biochemical analyses of cytochrome P-450IA1 in tissues of the ratoffceptus during the progression of organogenesis. Biochem Pharmacol 38:4027-36
Stark, K L; Juchau, M R (1989) Microinjection of cultured rat embryos: a new technique for studies in chemical dysmorphogenesis. Toxicol Appl Pharmacol 100:411-6
Juchau, M R (1989) Bioactivation in chemical teratogenesis. Annu Rev Pharmacol Toxicol 29:165-87
Beyer, B K; Stark, K L; Fantel, A G et al. (1989) Biotransformation, estrogenicity, and steroid structure as determinants of dysmorphogenic and generalized embryotoxic effects of steroidal and nonsteroidal estrogens. Toxicol Appl Pharmacol 98:113-27
Namkung, M J; Yang, H L; Hulla, J E et al. (1988) On the substrate specificity of cytochrome P450IIIA1. Mol Pharmacol 34:628-37
Beyer, B K; Juchau, M R (1988) Contrasting effects of estradiol-17 beta and 17 alpha-ethinyl estradiol-17 beta on cultured whole embryos. J Steroid Biochem 29:629-34

Showing the most recent 10 out of 12 publications